Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
SVP, Pharmaceutical Development
-
Stock Symbol
-
CRVS on Nasdaq
William Benton Jones - trading volume in the past year for Corvus Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
154K |
$266K |
$1.73 |
May 6, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
200K |
|
|
Dec 6, 2023 |
Direct |
Common Stock |
|
| Warrant (Right to Buy) |
19.4K |
|
|
May 6, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.